Circular RNAs are differentially expressed in prostate cancer and are potentially associated with resistance to enzalutamide

Most forms of castration-resistant prostate cancer (CRPC) are dependent on the androgen receptor (AR) for survival. While, enzalutamide provides a substantial survival benefit, it is not curative and many patients develop resistance to therapy. Although not yet fully understood, resistance can devel...

Descripción completa

Detalles Bibliográficos
Autores principales: Greene, John, Baird, Anne-Marie, Casey, Orla, Brady, Lauren, Blackshields, Gordon, Lim, Marvin, O’Brien, Odharnaith, Gray, Steven G., McDermott, Raymond, Finn, Stephen P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6656767/
https://www.ncbi.nlm.nih.gov/pubmed/31341219
http://dx.doi.org/10.1038/s41598-019-47189-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6656767/
https://www.ncbi.nlm.nih.gov/pubmed/31341219
http://dx.doi.org/10.1038/s41598-019-47189-2

Ejemplares similares